BCM
TAK icon

Bayesian Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Bayesian Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,197
Closed -$207K – 918
2021
Q4 		$207K Buy
+15,197
New +$213K 0.07% 318
2021
Q3 		– Sell
-14,222
Closed -$239K – 538
2021
Q2 		$239K Sell
14,222
-18,515
-57% -$315K 0.06% 335
2021
Q1 		$598K Buy
32,737
+14,300
+78% +$257K 0.14% 197
2020
Q4 		$336K Buy
18,437
+5,142
+39% +$90.2K 0.09% 281
2020
Q3 		$237K Buy
+13,295
New +$242K 0.06% 399
2020
Q2 		– Sell
-20,282
Closed -$308K – 774
2020
Q1 		$308K Buy
+20,282
New +$368K 0.07% 447

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return